chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 76-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 03-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitants medications was reported.  No treatments medications was reported.  It was reported that vaccine was administered 9 days from first puncture.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up received  contains no new information, but action taken updated to not applicable because the only event in the case is medication error.
Side of left toe had gone numb; Pain in upper back muscles; Slept the first half of the day; Felt like had a major surgery done; Muscles hurt; Hurt to breathe; Dizzy; Fatigued/exhausted; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 11May2021 at 08:45 (at the age of 33-years-old), as a single dose for COVID-19 immunisation. Medical history included borderline personality disorder, degenerative disc disease, have had 2 previous surgeries on L5-S1, also possibly suffered from small fiber neuropathy, fibromyalgia, and/or silent migraines. Concomitant medications included amitriptyline (MANUFACTURER UNKNOWN) and colecalciferol (VITAMIN D3); both for an unspecified indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ERE734) via an unspecified route of administration in the left arm on 20Apr2021 at 08:45 (at the age of 33-years-old), as a single dose for COVID-19 immunisation. The patient previously took gabapentin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11May2021, within an hour, the patient experienced sore arm and on 11May2021 by 22:00, the patient felt like she had a major surgery done, all of muscles were hurt, it was even hurting to breathe, felt dizzy and fatigued. On 12May2021, the next day, the patient was exhausted and slept the first half of the day and by the end of the day, at 22:00, the side of her left toe had gone numb and to the day of reporting, the patient could only feel pressure, and the pain in her upper back muscles was awful and had not gone away. The stretching and physical therapy exercises for the back (exercises taught from previous back issues), had not corrected the issue. The pain and numbness did not get better or worse and pain killers had no effect either. The patient was still fatigued. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events sore arm, hurt to breathe, pain in upper back muscles, muscles hurt and side of left toe had gone numb and included treatment with pain killers (unspecified) and stretching and physical therapy exercises. The clinical outcome of the events sore arm, felt like had a major surgery done, hurt to breathe, pain in upper back muscles, dizzy, muscles hurt, fatigued/exhausted, slept the first half of the day and side of left toe had gone numb were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient received first dose of COVID-19 vaccination on 03/06/2021 which was Moderna vaccination. Patient did not recall receiving previous dose of COVID-19 vaccination and signed up to receive dose of Pfizer COVID-19 Vaccination. Patient did receive a dose of Pfizer Vaccination on 05/04/20201 after previous dose of Moderna Vaccination
No additional AEs were reported; expired MMR II vaccine was given to a patient; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender.  The patient's pertinent medical history, current conditions, drug reactions or allergies and concomitant medications were not reported.  On 03-OCT-2022, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, recombinant human albumin (rHA) (M-M-R II) subcutaneous injection, 1 dose, lot #T031436, expiration date: 15-SEP-2022, administered for prophylaxis (strength, and route of administration were not provided) (expired product administered). No additional adverse events details or product quality complaints were reported (no adverse event).
pain at the injection site (I couldn't raise my arm over my head between hours 5 and 30); pain at the injection site (I couldn't raise my arm over my head between hours 5 and 30); This is a spontaneous report from a contactable consumer (patient) reported for herself (Internet Source). A female patient of unspecified age had received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: not provided), via an unspecified route of administration in Jan2021 as a single dose for COVID-19 immunisation. The patient's medical history and concomitant was not reported. The patient reported that, my only side effect so far has been an unusual amount of pain at the injection site (I couldn't raise my arm over my head between hours 5 and 30) in Jan2021, but it's much better today and the rest of me feels fine. The events were reported as non-serious. Facility where the most recent COVID-19 vaccine was administered was hospital. I was unknown if the patient receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown if the patient diagnosed with COVID-19 prior to vaccination and Since the vaccination, has the patient been tested for COVID-19. Outcome of the events was recovered in Jan2021.   Information on the lot/batch number has been requested.
This spontaneous report as received from a nurse refers to a patient of an unknown age and gender. The patient's medical history, concurrent condition and drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated with improperly stored dose of PROQUAD lot# N034561, expiration date: 03-JUN-2019 or lot# N025926, expiration date: 18-MAR-2019 (dose and route of administration were not reported) reconstituted with properly stored sterile diluent (MERCK) for prophylaxis. Administered dose of vaccine experienced the temperature excursion between -14 degrees Celsius to -10 degrees Celsius (also reported as -10.4 degrees Celsius) for 1 hour and 3 minutes. There was no previous temperature excursion. Digital data logger was involved. No adverse events were reported. This is one of four reports received from the same reporter. Lot numbers N034561 and N025926 have been verified to be valid lot numbers for measles, mumps, rubella and varicella (oka-merck) virus vaccine live with albumin status rHA. Sender's Comments: US-009507513-1806USA004463: US-009507513-1806USA004464: US-009507513-1806USA001112.
Pt began 23OCT91 AM w/fever & rash all over seen by MD given rx for diaper rash & told was allergic rxn to imun; rash cleared in 2-3 days; pt had sz x 2; taken to ER "quit breathing & turned blue";
PATIENT RECEIVED VACCINE THAT EXPERIENCED A TEMPERATURE EXCURSION, VACCINE WAS KEPT IN THE REFRIGERATOR FOR MORE THAN 30 DAYS. NO ADVERSE REACTION REPORTED PER PATIENT INTERVIEW.
Severe dizziness; Mouth breaking out in ulcers; extreme tiredness; headache; This is a spontaneous report from a contactable healthcare professional reporting for self. This 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 30Dec2020 04:30 PM at single dose (vaccine location: left arm) for COVID-19 immunisation. The patient previously experienced allergies with penicillin and levofloxacin (LEVOQUIN). Concomitant medications in two weeks included cetirizine hydrochloride (ZYRTEC), colecalciferol (VIATAMIN D) and hormone replacement pellets. Patient did not have other vaccine in four weeks. Patient was not pregnant at the time of vaccination. The patient experienced severe dizziness 36 hours after vaccination, mouth breaking out in ulcers, extreme tiredness and headache on 01Jan2021. No treatment received for events. Patient did not have COVID prior vaccination, and did not have COVID tested post vaccination. The outcome of events was recovering.   Information on the Lot/Batch number has been requested.
contracted Covid about 1 week ago; contracted Covid about 1 week ago; This is a spontaneous report from a non-contactable consumer (patient). A female patient of unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) the first and second dose, both on unknown date as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient is fully vaccinated but contracted Covid about 1 week ago before the time of reporting. Specific covid vaccine that the patient received is unknown, dated of administration are unknown. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
2 days after the shot, when I woke up, I could hardly move my legs. after a day or two, I was able to walk a couple of steps. Have to use a cane with 3 feet for stability. I was undergoing severe pain throughout this time. Pain from my lower back, left hip and left leg to left knee.  Was given physical therapy through the VA for 6 weeks and that helped loosen my leg up, but still in serious pain. After 2 months i am still in moderate pain but it is slowly lessening. VA has precsribed both Chiropractic and Massage treatments for me in the future.  I have lost 2 months of work and hit hard financially.
Joint Aches generalized after second dose of vaccine. Most joint pain resolved except for in her fingers.  Bilateral finger joint pain continues and has been constant since 2nd vaccine dose.  Joint pain, stiffness worse in morning and at night.
Itching/redness @ injection site..next day: red induration of injection site + pain in shoulder joint...10/20/2011 @ 1500: mild flu-like symptoms + bone/joint pain in all bones + joints...bone + joint pain continue w/o relief at the current time. Hospitalized 10/28/2011-10/29/2011. Seen by Inf. Dis/Allergist/Neurologist: all tests negative/normal. Unable to achieve pain relief w/ steroids/narcotics/gabapentin.
Mother phoned to state that patient received vaccines yesterday, vomited last evening, had swelling in both legs yesterday but only the Rt leg is swollen today to below his knee. Advised ice and Ibuprofen.
Administered  the  1 st dose of the Moderna COVID-19 Vaccine to a 12 years old female patient; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administered  the  1 st dose of the Moderna COVID-19 Vaccine to a 12 years old female patient) in a 12-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Aug-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administered  the  1 st dose of the Moderna COVID-19 Vaccine to a 12 years old female patient). On 13-Aug-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administered  the  1 st dose of the Moderna COVID-19 Vaccine to a 12 years old female patient) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product information was not provided. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Aug-2021: Follow-up Information received contains No Significant Information
The morning after booster vaccine, Patient fainted,  had ringing in ears,  and experienced hearing loss,.  She also vomited  and had a stomach ache.  She also had a headache.  She was very lethargic.  This evening she still has queasy stomach and some ringing in ears though improved since this morning.
Information has been received from a pharmacist and nurse on 06-AUG-2010. A 71 year-old hospitalized female received flu vaccine (manufacturer unspecified) on 05-FEB-2010 as a routine order prior to discharge. No concurrent vaccinations were performed at the time. Concomitant therapy was unspecified by reporters. Medical history included allergy to aspirin, COUMADIN and Metformin. After hospital discharge and at home, the patient developed redness and swelling of her right arm at the injection site. This progressed to an "eaten away" area on her arm. On 22-MAR-2010, the patient was re-hospitalized for wound packing treatment and VANCOMYCIN. The pharmacist "thought" the patient had a wound culture revealing methicillin resistant staphylococcus infection (MRSA). The patient was discharged on 08-APR-2010 and was recovering. On 29-JUL-2010, the nurse refused to provide any additional information. No further information is expected. This case was originally reported to Merck and Co., Inc. (manufacturer case# 1003USA04591). The company considered event serious due to patient hospitalization. The company considered events possible to flu vaccine, however, brand is unspecified. Information derived from this AE report does not change the current safety profile of the product.
A report has been received from a Pharmacist concerning a 16 year old, female subject, who had been receiving FLUMIST. FLUMIST started on 11-Nov-2013. The reporter stated that the patient was administered only a half dose of FLUMIST in one nostril which started on 11-Nov-2013. The outcome of the event of administration of only a half dose of FLUMIST in one nostril is unknown. The report was considered to be non-serious.
Developed left deltoid pain and slightly swelling at the injection site within 2 hours of vaccination. He got a high dose influenza vaccine in the right arm on the same day. Within about 12 hours he developed diffuse joint pains. Within 2 days, he noticed a large area of redness of the left underarm and now spreading to the left chest and abdomen. Also developed erythematous red rash on b/l lower legs as well. No itching. No fever.
Patient experienced numbness and tingling in her tongue and toes. I asked the patient to sit down by the pharmacy so I could watch her and offered to call her physician but she declined. After 10 minutes I talked to her and she said she experienced this before when she took Zyrtec. I told her if the symptoms did not go away she should contact her physician immediately and she agreed.
Runny nose; Some achiness; glands on the left side were swollen/swollen glands in neck; Mild Headache; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose), PAIN (Some achiness), LYMPHADENOPATHY (glands on the left side were swollen/swollen glands in neck) and HEADACHE (Mild Headache) in a 72-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 012M20A) for COVID-19 vaccination.     The patient's past medical history included Polymyalgia rheumatica (Currently in Remission Since June 2020) in October 2020, Blood pressure high and GERD. Concurrent medical conditions included Hypothyroidism since 1991, Sulfonamide allergy, Drug allergy (Dorzolamide), Latex allergy and Fructose. Concomitant products included PIROXICAM (MAXIDENE), TIMOLOL MALEATE (LOTENSIN [TIMOLOL MALEATE]) and NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) for Blood pressure high, ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]) for GERD.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced RHINORRHOEA (Runny nose), PAIN (Some achiness), LYMPHADENOPATHY (glands on the left side were swollen/swollen glands in neck) and HEADACHE (Mild Headache). At the time of the report, RHINORRHOEA (Runny nose) had not resolved, PAIN (Some achiness) outcome was unknown and LYMPHADENOPATHY (glands on the left side were swollen/swollen glands in neck) and HEADACHE (Mild Headache) had resolved.            Concomitant medication also included : Thyroid Compound Med (ongoing)  (oral) 88/28 mcg for hypothyroidism. Patient stated that  only other possible complicating factor might be that patient  had had an epidural injection 2 weeks prior to final Moderna Vaccine injection.  Patient called that doctor's office who  told  that the Epidural could not possibly have been a factor.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Patient demographics, medical history, vaccination facility details, dose details, concomitant medications and events  added.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Loss of apetite; Vomit; fever; Weakness/ loss of energy; Sleepy; Bed ridden; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (Bed ridden), DECREASED APPETITE (Loss of apetite), ASTHENIA (Weakness/ loss of energy), SOMNOLENCE (Sleepy) and VOMITING (Vomit) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014m20a and 032l20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pacemaker insertion (cardiac). Concurrent medical conditions included AFib and Blood pressure fluctuation (unspecified). Concomitant products included LOSARTAN, APIXABAN (ELIQUIS), PROPAFENONE HCL and DORZOLAMIDE HYDROCHLORIDE, TIMOLOL MALEATE (DORZOLAMIDE TIMOLOL) for an unknown indication.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced BEDRIDDEN (Bed ridden), ASTHENIA (Weakness/ loss of energy) and SOMNOLENCE (Sleepy). On an unknown date, the patient experienced DECREASED APPETITE (Loss of apetite), VOMITING (Vomit) and PYREXIA (fever). On 05-Mar-2021, BEDRIDDEN (Bed ridden), ASTHENIA (Weakness/ loss of energy) and SOMNOLENCE (Sleepy) had resolved. At the time of the report, DECREASED APPETITE (Loss of apetite), VOMITING (Vomit) and PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Oct-2020, SARS-CoV-2 test: positive (Positive) Positive.         Treatment medication use was not provided by the reporter.    The action taken with mRNA 1273 with the events was considered as not applicable.   This case was linked to MOD-2021-024666 (Patient Link).
Patient called pharmacy on 1/20/14 complaining of redness, itching, and warmth around injection site.
metal taste in her mouth; She also felt like she was burning up inside; She was sweating and her body felt extremely warm inside; This is a spontaneous report from a contactable other healthcare professional (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration on 21Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the COVID vaccine morning on 21Jan2021, and 15 to 30 minutes later, she had a metal taste in her mouth and was still having the metal taste in her mouth. She also felt like she was burning up inside out. She was sweating and her body felt extremely warm inside. Events were reported as non-serious. Outcome of the event metal taste in her mouth was not recovered, while unknown for the other events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Right upper arm (deltoid region) is red, swollen, hot to touch, itchy, painful with a hardened induration.  The redness measures approx. 2.5in x 1.5in.  Dr. observed pts arm suggest to ice for 20 mins every hour. Rx called to Pharmacy for Keflex 500mg 2 pills twice per day for 10 days.
Patient reports left sided facial and arm numbness within 15 minutes of receiving the vaccine. He continues to have left sided facial numbness 10 days post vaccine. He had bilateral thigh weakness and bilateral feet numbness and tingling after the vaccine. He went to the Emergency Department on 9/14/2021 because of these complaints. His exam on 9/20 shows slight left sided facial droop and slight nystagmus when looking right, otherwise normal.
This is a spontaneous report from a contactable physician via a Pfizer sales Representative. A 17-year-old male patient of an unspecified race received TRUMENBA via an unspecified route at single dose, in the right arm, on 14Nov2016. Relevant medical history included muscular dystrophy. On an unknown date the patient experienced soreness fever and fatigue. The outcome of the events was unknown.
6/3 tenderness at site later in day and then redness later on.  6/4 pain decreased to elbow and that night redness 1 1/2" x 3" around site.  6/5 pain and tenderness into shoulders and neck - antibiotic given (Levaquin 500 mg x 5 d).  6/6 painful muscles right side chest - Prednisone dose pak given (redness resolving).  6/8 tenderness gone, symptoms resolved.
first noc p/vax, felt hot & nausea; 16 days p/vax, went to ER when airway started to close up; dx @ that time w/serum sickness;
Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Additional Details: extremeties
Induration 5" in diameter with 5" of erythema (left thigh). Will follow. Pt instructed to take children's Tylenol/Motrin for fever and pain. RTC if symptoms worsen